Eric Andersen, Director at MERRIMACK PHARMACEUTICALS INC (MACK), bought 98,243 shares at $13.15 ($1.3M) on 2023-12-26, disclosed to the SEC on 2023-12-28.
Open-market purchase of $1.3M MACK by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.15 | 48,693 | $640K | 49.6% |
| 2 | $13.15 | 48,693 | $640K | 49.6% |
| 3 | $13.35 | 857 | $11K | 0.9% |
| Total | $13.15 avg | 98,243 | $1.3M | 100% |
| Filing → |
| MACK | BUY | 2023-11-14 | $1.3M | — | Filing → |
| MACK | BUY | 2023-08-09 | $2.7M | — | Filing → |
| AON | SELL | 2023-05-11 | $2.5M | — | Filing → |